{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:23:04Z","timestamp":1791235384824,"version":"4.1.0"},"reference-count":79,"publisher":"The Company of Biologists","issue":"12","license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"crossref","award":["101550\/Z\/13\/Z"],"award-info":[{"award-number":["101550\/Z\/13\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015226","name":"Royal Veterinary College","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Duchenne muscular dystrophy (DMD) is a fatal muscle-wasting disease, caused by mutations in the dystrophin gene, characterised by cycles of muscle degeneration, inflammation and regeneration. Recently, there has been renewed interest specifically in drugs that ameliorate muscle inflammation in DMD patients. The DE50-MD dog is a model of DMD that closely mimics the human DMD phenotype. We quantified inflammatory proteins in serum from wild-type (WT) and DE50-MD dogs aged 3-18\u2005months to identify biomarkers for future pre-clinical trials. Significantly higher concentrations of C-C motif chemokine ligand 2 (CCL2), granulocyte-macrophage colony-stimulating factor (GM-CSF or CSF2), keratinocyte chemotactic-like (KC-like, homologous to mouse CXCL1), TNF\u03b1 (or TNF), and interleukins IL2, IL6, IL7, IL8 (CXCL8), IL10, IL15 and IL18 were detected in DE50-MD serum compared to WT serum. Of these, CCL2 best differentiated the two genotypes. The relative level of CCL2 mRNA was greater in the vastus lateralis muscle of DE50-MD dogs than in that of WT dogs, and CCL2 was expressed both within and at the periphery of damaged myofibres. Serum CCL2 concentration was significantly associated with acid phosphatase staining in vastus lateralis biopsy samples in DE50-MD dogs. In conclusion, the serum cytokine profile suggests that inflammation is a feature of the DE50-MD phenotype. Quantification of serum CCL2 in particular is a useful non-invasive biomarker of the DE50-MD phenotype.<\/jats:p>","DOI":"10.1242\/dmm.049394","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T07:51:36Z","timestamp":1669708296000},"source":"Crossref","is-referenced-by-count":21,"title":["Serum inflammatory cytokines as disease biomarkers in the DE50-MD dog model of Duchenne muscular dystrophy"],"prefix":"10.1242","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1614-504X","authenticated-orcid":false,"given":"Dominique O.","family":"Riddell","sequence":"first","affiliation":[{"name":"Royal Veterinary College 1 Comparative Neuromuscular Diseases Laboratory, Department of Clinical Science and Services , , Camden, London NW1 0TU , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2283-2118","authenticated-orcid":false,"given":"John C. W.","family":"Hildyard","sequence":"additional","affiliation":[{"name":"Royal Veterinary College 1 Comparative Neuromuscular Diseases Laboratory, Department of Clinical Science and Services , , Camden, London NW1 0TU , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9418-0708","authenticated-orcid":false,"given":"Rachel C. M.","family":"Harron","sequence":"additional","affiliation":[{"name":"Royal Veterinary College 1 Comparative Neuromuscular Diseases Laboratory, Department of Clinical Science and Services , , Camden, London NW1 0TU , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6158-640X","authenticated-orcid":false,"given":"Natasha L.","family":"Hornby","sequence":"additional","affiliation":[{"name":"Royal Veterinary College 1 Comparative Neuromuscular Diseases Laboratory, Department of Clinical Science and Services , , Camden, London NW1 0TU , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1425-6344","authenticated-orcid":false,"given":"Dominic J.","family":"Wells","sequence":"additional","affiliation":[{"name":"Royal Veterinary College 2 Department of Comparative Biomedical Sciences , , Camden, London NW1 0TU , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4344-6438","authenticated-orcid":false,"given":"Richard J.","family":"Piercy","sequence":"additional","affiliation":[{"name":"Royal Veterinary College 1 Comparative Neuromuscular Diseases Laboratory, Department of Clinical Science and Services , , Camden, London NW1 0TU , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"key":"2022120909295696100_DMM049394C1","first-page":"94","article-title":"Markers of degeneration and regeneration in Duchenne muscular dystrophy","volume":"28","author":"Abdel-Salam","year":"2009","journal-title":"Acta Myologica"},{"key":"2022120909295696100_DMM049394C2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1126\/science.aau1549","article-title":"Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy","volume":"362","author":"Amoasii","year":"2018","journal-title":"Science (New York N.Y.)"},{"key":"2022120909295696100_DMM049394C3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1046\/j.1365-2796.2001.00867.x","article-title":"Chemokines in pathology and medicine","volume":"250","author":"Baggiolini","year":"2001","journal-title":"J. Intern. Med."},{"key":"2022120909295696100_DMM049394C4","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1242\/dmm.016014","article-title":"Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy","volume":"7","author":"Barth\u00e9l\u00e9my","year":"2014","journal-title":"Dis. Model. Mech."},{"key":"2022120909295696100_DMM049394C5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3233\/JND-190394","article-title":"The dog model in the spotlight: legacy of a trustful cooperation","volume":"6","author":"Barth\u00e9l\u00e9my","year":"2019","journal-title":"J. Neuromuscul. Dis."},{"key":"2022120909295696100_DMM049394C6","doi-asserted-by":"publisher","first-page":"e0153461","DOI":"10.1371\/journal.pone.0153461","article-title":"Discovery of metabolic biomarkers for duchenne muscular dystrophy within a natural history study","volume":"11","author":"Boca","year":"2016","journal-title":"PLoS ONE"},{"key":"2022120909295696100_DMM049394C7","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0002-9440(10)65050-X","article-title":"Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors","volume":"156","author":"Cai","year":"2000","journal-title":"Am. J. Pathol."},{"key":"2022120909295696100_DMM049394C8","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.3390\/cells9071659","article-title":"\u201cThe Social Network\u201d and muscular dystrophies: the lesson learnt about the niche environment as a target for therapeutic strategies","volume":"9","author":"Cappellari","year":"2020","journal-title":"Cells"},{"key":"2022120909295696100_DMM049394C9","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3389\/fimmu.2020.01259","article-title":"Multiple roles for chemokines in neutrophil biology","volume":"11","author":"Capucetti","year":"2020","journal-title":"Front. Immunol."},{"key":"2022120909295696100_DMM049394C10","first-page":"151","article-title":"Multi-slice MRI reveals heterogeneity in disease distribution along the length of muscle in Duchenne muscular dystrophy","volume":"36","author":"Chrzanowski","year":"2017","journal-title":"Acta Myol."},{"key":"2022120909295696100_DMM049394C11","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.1093\/hmg\/ddw237","article-title":"Selective release of muscle-specific, extracellular microRNAs during myogenic differentiation","volume":"25","author":"Coenen-Stass","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"2022120909295696100_DMM049394C12","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1177\/002215540104900807","article-title":"The role of tumor necrosis factor-alpha (TNF-alpha) in skeletal muscle regeneration. Studies in TNF-alpha(\u2212\/\u2212) and TNF-alpha(\u2212\/\u2212)\/LT-alpha(\u2212\/\u2212) mice","volume":"49","author":"Collins","year":"2001","journal-title":"J. Histochem. Cytochem."},{"key":"2022120909295696100_DMM049394C13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.phrs.2018.09.007","article-title":"Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug","volume":"136","author":"Conklin","year":"2018","journal-title":"Pharmacol. Res."},{"key":"2022120909295696100_DMM049394C14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1556\/APhysiol.96.2009.2.4","article-title":"Impact of repeated bouts of eccentric exercise on sarcolemma disruption in human skeletal muscle","volume":"96","author":"Costa","year":"2009","journal-title":"Acta Physiol. Hung."},{"key":"2022120909295696100_DMM049394C15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1083\/jcb.201402079","article-title":"Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy","volume":"207","author":"Dadgar","year":"2014","journal-title":"J. Cell Biol."},{"key":"2022120909295696100_DMM049394C16","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/mus.23481","article-title":"Upregulation of chemokines and their receptors in Duchenne muscular dystrophy: potential for attenuation of myofiber necrosis","volume":"46","author":"De Paepe","year":"2012","journal-title":"Muscle Nerve"},{"key":"2022120909295696100_DMM049394C17","doi-asserted-by":"publisher","first-page":"6264","DOI":"10.1038\/s41467-021-26516-0","article-title":"Resolvin-D2 targets myogenic cells and improves muscle regeneration in Duchenne muscular dystrophy","volume":"12","author":"Dort","year":"2021","journal-title":"Nat. Commun."},{"key":"2022120909295696100_DMM049394C18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"2022120909295696100_DMM049394C19","volume-title":"Muscle Biopsy","author":"Dubowitz","year":"2021"},{"key":"2022120909295696100_DMM049394C20","author":"Duchenne","year":"1868"},{"key":"2022120909295696100_DMM049394C21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13395-015-0041-y","article-title":"Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia","volume":"5","author":"Duddy","year":"2015","journal-title":"Skelet. Muscle"},{"key":"2022120909295696100_DMM049394C22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/1097-4644(2000)79:1&lt;164::AID-JCB10&gt;3.0.CO;2-D","article-title":"Identification of the increased expression of monocyte chemoattractant protein-1, cathepsin S, UPIX-1, and other genes in dystrophin-deficient mouse muscles by suppression subtractive hybridization","volume":"79","author":"Fang","year":"2000","journal-title":"J. Cell. Biochem."},{"key":"2022120909295696100_DMM049394C23","doi-asserted-by":"publisher","first-page":"e0190474","DOI":"10.1371\/journal.pone.0190474","article-title":"MCP-1, KC-like and IL-8 as critical mediators of pathogenesis caused by Babesia canis","volume":"13","author":"Gal\u00e1n","year":"2018","journal-title":"PLoS ONE"},{"key":"2022120909295696100_DMM049394C24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/jlb.55.2.259","article-title":"The monoclonal antibody MAC387 detects an epitope on the calcium-binding protein MRP14","volume":"55","author":"Goebeler","year":"1994","journal-title":"J. Leukoc. Biol."},{"key":"2022120909295696100_DMM049394C25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0960-8966(94)90068-X","article-title":"Dystrophin-deficient myofibers are vulnerable to mast cell granule-induced necrosis","volume":"4","author":"Gorospe","year":"1994","journal-title":"Neuromuscul. Disord."},{"key":"2022120909295696100_DMM049394C26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0022-510X(95)00255-Z","article-title":"Recruitment of mast cells to muscle after mild damage","volume":"135","author":"Gorospe","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"2022120909295696100_DMM049394C27","doi-asserted-by":"publisher","first-page":"43697","DOI":"10.1038\/srep43697","article-title":"Identification of serum protein biomarkers for utrophin based DMD therapy","volume":"7","author":"Guiraud","year":"2017","journal-title":"Sci. Rep."},{"key":"2022120909295696100_DMM049394C28","doi-asserted-by":"publisher","first-page":"e90341","DOI":"10.1172\/jci.insight.90341","article-title":"Disease-modifying effects of orally bioavailable NF-\u03baB inhibitors in dystrophin-deficient muscle","volume":"1","author":"Hammers","year":"2016","journal-title":"JCI insight"},{"key":"2022120909295696100_DMM049394C29","doi-asserted-by":"publisher","first-page":"6458","DOI":"10.1093\/hmg\/ddu366","article-title":"Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients","volume":"23","author":"Hathout","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"2022120909295696100_DMM049394C30","doi-asserted-by":"publisher","first-page":"7153","DOI":"10.1073\/pnas.1507719112","article-title":"Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy","volume":"112","author":"Hathout","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2022120909295696100_DMM049394C31","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/emmm.201302621","article-title":"VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects","volume":"5","author":"Heier","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"2022120909295696100_DMM049394C32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3233\/JND-170267","article-title":"Determination of qpcr reference genes suitable for normalizing gene expression in a canine model of duchenne muscular dystrophy","volume":"5","author":"Hildyard","year":"2018","journal-title":"J. Neuromuscular Dis."},{"key":"2022120909295696100_DMM049394C33","doi-asserted-by":"publisher","first-page":"238","DOI":"10.12688\/wellcomeopenres.18251.1","article-title":"The skeletal muscle phenotype of the DE50-MD dog model of Duchenne muscular dystrophy [version 1; peer review: awaiting peer review]","volume":"7","author":"Hildyard","year":"2022","journal-title":"Wellcome Open Res."},{"key":"2022120909295696100_DMM049394C34","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.nmd.2006.06.011","article-title":"Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNF\u03b1 function with Etanercept in mdx mice","volume":"16","author":"Hodgetts","year":"2006","journal-title":"Neuromuscul. Disord."},{"key":"2022120909295696100_DMM049394C35","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.nmd.2021.05.010","article-title":"Musculoskeletal magnetic resonance imaging in the DE50-MD dog model of Duchenne muscular dystrophy","volume":"31","author":"Hornby","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"2022120909295696100_DMM049394C36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jvs.2005.04.046","article-title":"CXC chemokine expression and synthesis in skeletal muscle during ischemia\/reperfusion","volume":"42","author":"Hua","year":"2005","journal-title":"J. Vasc. Surg."},{"key":"2022120909295696100_DMM049394C37","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1016\/j.ajpath.2014.07.021","article-title":"Serum profiling identifies novel muscle miRNA and cardiomyopathy-related miRNA biomarkers in golden retriever muscular dystrophy dogs and duchenne muscular dystrophy patients","volume":"184","author":"Jeanson-Leh","year":"2014","journal-title":"Am. J. Pathol."},{"key":"2022120909295696100_DMM049394C38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/978-1-4939-3228-3_12","article-title":"Canine-Inherited Dystrophinopathies and Centronuclear Myopathies. In","author":"Kornegay","year":"2016","journal-title":"Regenerative Medicine for Degenerative Muscle Diseases (Stem Cell Biology and Regenerative Medicine)"},{"key":"2022120909295696100_DMM049394C39","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.pmr.2011.11.014","article-title":"The paradox of muscle hypertrophy in muscular dystrophy","volume":"23","author":"Kornegay","year":"2012","journal-title":"Phys. Med. Rehabil. Clin. N Am."},{"key":"2022120909295696100_DMM049394C40","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41390-019-0427-3","article-title":"Dystrophin deficiency promotes leukocyte recruitment in mdx mice","volume":"86","author":"Kranig","year":"2019","journal-title":"Pediatr. Res."},{"key":"2022120909295696100_DMM049394C41","doi-asserted-by":"publisher","first-page":"i10","DOI":"10.18637\/jss.v054.i10","article-title":"GLIMMPSE: online power computation for linear models with and without a baseline covariate","volume":"54","author":"Kreidler","year":"2013","journal-title":"J. Stat. Softw."},{"key":"2022120909295696100_DMM049394C42","doi-asserted-by":"publisher","first-page":"e0194421","DOI":"10.1371\/journal.pone.0194421","article-title":"The dual CCR2\/CCR5 chemokine receptor antagonist Cenicriviroc reduces macrophage infiltration and disease severity in Duchenne muscular dystrophy (Dmdmdx-4Cv) mice","volume":"13","author":"Liang","year":"2018","journal-title":"PLoS ONE"},{"key":"2022120909295696100_DMM049394C43","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.1096\/fj.10-178939","article-title":"Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair","volume":"25","author":"Lu","year":"2011","journal-title":"FASEB J."},{"key":"2022120909295696100_DMM049394C44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/84298","article-title":"Chemokines: immunology's high impact factors","volume":"2","author":"Mackay","year":"2001","journal-title":"Nat. Immunol."},{"key":"2022120909295696100_DMM049394C45","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0022-510X(90)90156-H","article-title":"Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy","volume":"99","author":"Mcdouall","year":"1990","journal-title":"J. Neurol. Sci."},{"key":"2022120909295696100_DMM049394C46","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1056\/NEJM198906153202405","article-title":"Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy","volume":"320","author":"Mendell","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"2022120909295696100_DMM049394C47","first-page":"16","article-title":"Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age","volume":"30","author":"Messina","year":"2011","journal-title":"Acta Myol."},{"key":"2022120909295696100_DMM049394C48","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J. Immunol."},{"key":"2022120909295696100_DMM049394C49","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1111\/febs.12338","article-title":"Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?","volume":"280","author":"Mu\u00f1oz-C\u00e1noves","year":"2013","journal-title":"FEBS J."},{"key":"2022120909295696100_DMM049394C50","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s41232-016-0019-0","article-title":"Inflammatory predisposition predicts disease phenotypes in muscular dystrophy","volume":"36","author":"Nitahara-Kasahara","year":"2016","journal-title":"Inflamm. Regener."},{"key":"2022120909295696100_DMM049394C51","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3390\/life11080827","article-title":"Validation of chemokine biomarkers in Duchenne muscular dystrophy","volume":"11","author":"Ogundele","year":"2021","journal-title":"Life (Basel)"},{"key":"2022120909295696100_DMM049394C52","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1939-165X.2006.tb00134.x","article-title":"Comparison of white blood cell differential percentages determined by the in-house LaserCyte hematology analyzer and a manual method","volume":"35","author":"Papasouliotis","year":"2006","journal-title":"Vet. Clin. Pathol."},{"key":"2022120909295696100_DMM049394C53","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0022-510X(94)00276-T","article-title":"mdx mice show progressive weakness and muscle deterioration with age","volume":"129","author":"Pastoret","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"2022120909295696100_DMM049394C54","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1096\/fj.06-7285com","article-title":"Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression","volume":"21","author":"Pescatori","year":"2007","journal-title":"FASEB J."},{"key":"2022120909295696100_DMM049394C55","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1055\/s-0037-1614521","article-title":"Haemostatic abnormalities, cardiac involvement and serum tumor necrosis factor levels in X-linked dystrophic patients","volume":"81","author":"Porreca","year":"1999","journal-title":"Thromb. Haemost."},{"key":"2022120909295696100_DMM049394C56","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/s0960-8966(02)00242-0","article-title":"Persistent over-expression of specific CC class chemokines correlates with macrophage and T-cell recruitment in mdx skeletal muscle","volume":"13","author":"Porter","year":"2003","journal-title":"Neuromuscul. Disord."},{"key":"2022120909295696100_DMM049394C57","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.nbd.2006.03.016","article-title":"Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice","volume":"23","author":"Radley","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"2022120909295696100_DMM049394C58","doi-asserted-by":"publisher","first-page":"eabh3693","DOI":"10.1126\/sciadv.abh3693","article-title":"Anti-inflammatory nanoparticles significantly improve muscle function in a murine model of advanced muscular dystrophy","volume":"7","author":"Raimondo","year":"2021","journal-title":"Sci. Adv."},{"key":"2022120909295696100_DMM049394C59","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/jemt.1172","article-title":"Role of nitric oxide in the pathogenesis of muscular dystrophies: a \u201ctwo hit\u201d hypothesis of the cause of muscle necrosis","volume":"55","author":"Rando","year":"2001","journal-title":"Microsc. Res. Tech."},{"key":"2022120909295696100_DMM049394C60","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/S0960-8966(18)30336-5","article-title":"Progressive age-associated decline in resistance to electrically-induced repetitive eccentric tibiotarsal flexion torque in the deltaE50-MD dog","volume":"28","author":"Riddell","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"2022120909295696100_DMM049394C61","doi-asserted-by":"publisher","first-page":"354","DOI":"10.12688\/wellcomeopenres.17398.1","article-title":"Longitudinal assessment of blood-borne musculoskeletal disease biomarkers in the DE50-MD dog model of Duchenne muscular dystrophy [version 1; peer review: 2 approved]","volume":"6","author":"Riddell","year":"2021","journal-title":"Wellcome Open Res."},{"key":"2022120909295696100_DMM049394C62","doi-asserted-by":"publisher","first-page":"4916","DOI":"10.1093\/hmg\/ddv214","article-title":"Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies","volume":"24","author":"Rouillon","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"2022120909295696100_DMM049394C63","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1002\/jbmr.410","article-title":"Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans","volume":"26","author":"Rufo","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"2022120909295696100_DMM049394C64","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1093\/clinchem\/46.10.1703","article-title":"A sensitive assay of tumor necrosis factor \u03b1 in sera from Duchenne muscular dystrophy patients","volume":"46","author":"Saito","year":"2000","journal-title":"Clin. Chem."},{"key":"2022120909295696100_DMM049394C65","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1212\/WNL.34.1.60","article-title":"Regenerated muscle fibers in Duchenne muscular dystrophy: a serial section study","volume":"34","author":"Schmalbruch","year":"1984","journal-title":"Neurology"},{"key":"2022120909295696100_DMM049394C66","first-page":"145","article-title":"Major clinical and histopathological characteristics of canine X-linked muscular dystrophy in Japan, CXMDJ","volume":"24","author":"Shimatsu","year":"2005","journal-title":"Acta Myol."},{"key":"2022120909295696100_DMM049394C67","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1161\/CIRCULATIONAHA.110.009910","article-title":"Loss of myeloid related protein-8\/14 exacerbates cardiac allograft rejection","volume":"124","author":"Shimizu","year":"2011","journal-title":"Circulation"},{"key":"2022120909295696100_DMM049394C68","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1016\/j.biocel.2013.05.001","article-title":"Wasting mechanisms in muscular dystrophy","volume":"45","author":"Shin","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2022120909295696100_DMM049394C69","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1083\/jcb.139.2.375","article-title":"Animal models for muscular dystrophy show different patterns of sarcolemmal disruption","volume":"139","author":"Straub","year":"1997","journal-title":"J. Cell Biol."},{"key":"2022120909295696100_DMM049394C70","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.redox.2016.08.016","article-title":"Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy","volume":"9","author":"Terrill","year":"2016","journal-title":"Redox. Biol."},{"key":"2022120909295696100_DMM049394C71","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0022-510X(88)90206-7","article-title":"Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies","volume":"88","author":"Valentine","year":"1988","journal-title":"J. Neurol. Sci."},{"key":"2022120909295696100_DMM049394C72","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/0300985816646432","article-title":"Lung inflammation associated with clinical acute necrotizing pancreatitis in dogs","volume":"54","author":"Vrolyk","year":"2017","journal-title":"Vet. Pathol."},{"key":"2022120909295696100_DMM049394C73","doi-asserted-by":"publisher","first-page":"e8647","DOI":"10.1371\/journal.pone.0008647","article-title":"A Duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier King Charles spaniels is amenable to Exon 51 skipping","volume":"5","author":"Walmsley","year":"2010","journal-title":"PLoS ONE"},{"key":"2022120909295696100_DMM049394C74","doi-asserted-by":"publisher","first-page":"C1031","DOI":"10.1152\/ajpcell.00467.2003","article-title":"Role of CC chemokines in skeletal muscle functional restoration after injury","volume":"286","author":"Warren","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"2022120909295696100_DMM049394C75","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"2022120909295696100_DMM049394C76","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41401-020-00515-1","article-title":"Catalpol counteracts the pathology in a mouse model of Duchenne muscular dystrophy by inhibiting the TGF-\u03b21\/TAK1 signaling pathway","volume":"42","author":"Xu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"2022120909295696100_DMM049394C77","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1113\/jphysiol.2008.152090","article-title":"CC family chemokines directly regulate myoblast responses to skeletal muscle injury","volume":"586","author":"Yahiaoui","year":"2008","journal-title":"J. Physiol."},{"key":"2022120909295696100_DMM049394C78","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1471-2105-13-134","article-title":"Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction","volume":"13","author":"Ye","year":"2012","journal-title":"BMC Bioinformatics"},{"key":"2022120909295696100_DMM049394C79","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1096\/fj.201600619r","article-title":"CCR2 deficiency does not provide sustained improvement of muscular dystrophy in mdx5cv mice","volume":"31","author":"Zhao","year":"2017","journal-title":"FASEB J."}],"container-title":["Disease Models &amp; Mechanisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.049394\/2346518\/dmm049394.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.049394\/2370219\/dmm049394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.049394\/2370219\/dmm049394.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T04:30:19Z","timestamp":1670560219000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/dmm\/article\/15\/12\/dmm049394\/285901\/Serum-inflammatory-cytokines-as-disease-biomarkers"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":79,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12,1]]}},"URL":"https:\/\/doi.org\/10.1242\/dmm.049394","relation":{},"ISSN":["1754-8403","1754-8411"],"issn-type":[{"value":"1754-8403","type":"print"},{"value":"1754-8411","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"article-number":"dmm049394"}}